Covered recipient · General Payments record
ISABEL D GONCALVES
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2022
$1,569.01
- Reported across 81 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $321.76 | 18 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $166.57 | 11 |
| MAYNE PHARMA COMMERCIAL LLC | $55.75 | 2 |
| Exeltis, USA Inc. | $27.23 | 1 |
| UROVANT SCIENCES INC | $22.61 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.76 | 1 |
| Agile Therapeutics, Inc. | $16.57 | 1 |
| Organon LLC | $14.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.30 | 04/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892664921 | CMS |
| ABBVIE INC. | $13.02 | 04/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892664923 | CMS |
| ABBVIE INC. | $19.48 | 05/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892664925 | CMS |
| ABBVIE INC. | $7.25 | 05/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892664927 | CMS |
| ABBVIE INC. | $3.82 | 07/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892664929 | CMS |
| ABBVIE INC. | $19.23 | 07/20/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892664931 | CMS |
| ABBVIE INC. | $5.93 | 08/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892664933 | CMS |
| ABBVIE INC. | $20.19 | 08/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892664935 | CMS |
| ABBVIE INC. | $13.80 | 10/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892664937 | CMS |
| ABBVIE INC. | $9.49 | 10/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892664939 | CMS |
| ABBVIE INC. | $29.06 | 12/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892664941 | CMS |
| Agile Therapeutics, Inc. | $16.57 | 03/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 957204837 | CMS |
| Bayer HealthCare Pharmaceuticals Inc. | $18.76 | 05/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 929773117 | CMS |
| Exeltis, USA Inc. | $27.23 | 08/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 951307613 | CMS |
| MAYNE PHARMA INC. | $29.89 | 10/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 959840845 | CMS |
| MAYNE PHARMA INC. | $25.86 | 11/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 959953605 | CMS |
| Organon LLC | $14.27 | 02/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 1022254649 | CMS |
| UROVANT SCIENCES INC | $22.61 | 07/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 931061901 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.